Previous 10 | Next 10 |
Arena Pharmaceuticals (NASDAQ: ARNA ) is scheduled to announce Q1 earnings results on Thursday, May 7th, after market close. The consensus EPS Estimate is -$2.42 vs. $12.10 in 1Q19 and the consensus Revenue Estimate is $1.58M vs. $801M in 1Q19. Over the last 2 years, ARNA has bea...
SAN DIEGO , May 6, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Preston Klassen , MD, MHS, the Company's Executive Vice President, Head of Research & Development, is scheduled to participate in a virtual fireside chat at the Bank of America S...
SAN DIEGO , April 30, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its first quarter 2020 financial results and provide a corporate update on Thursday, May 7, 2020 , after the close of the U.S. financial markets. The Company will host a question and...
It's been a wild ride for pot stocks already in 2020. Last year, the Horizons Marijuana Life Sciences ETF (OTC: HMLSF) fell by 39% while the S&P 500 soared by 31%. This year, the Life Sciences ETF is already down 35%, except this time the S&P 500 is also down by 11%. Unfortunatel...
SAN DIEGO , April 10, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi , the Company's President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 19th Annual Needham Healthcare Conference on T...
We're now going through the hard part of the stock-market crash. The relentless downward momentum has eased, and we've even seen some rallies, not to mention indications that the coronavirus curve is in fact leveling (e.g., the New York City epicenter ). But bear market rallies are real ...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Merck Announces Upbeat Keytruda Data for Colorectal Cancer Merck ( MRK ) reported positive preliminary results from its Phase 3 clinical trial of Keytruda. The trial KEYNOTE 177 is designed to evaluate the performance of the drug candidate as the first-line treatment of patients with micro...
Arena Pharmaceuticals (NASDAQ: ARNA ) is stoked over topline data from a Phase 1 clinical trial evaluating controlled-release (CR) delivery profiles of lead drug etrasimod. More news on: Arena Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
SAN DIEGO , April 1, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced positive topline data from a Phase 1 clinical study evaluating controlled-release delivery profiles (CR) for its investigational agent, etrasimod, a highly selective, once-daily, or...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...